ACCESS Newswire
23 Jan 2023, 19:35 GMT+10
NAPOLEONVILLE, LA / ACCESSWIRE / January 23, 2023 / (OTC PINK:IFUS) Consistent with the Company's grant application to the U.S.D.A., IFUS has secured additional funding to continue testing/validation of it's Supreme Gold Plus™ Proprietary Technology and Formulation for Beef and Dairy Cattle. This testing meets the requirements outlined by U.S.D.A. to include Next Gen improvement in the application of the technology as well as the formulation to validate:
This next stage of testing is designed to expand qualitative and quantitative definitive proof of Supreme Gold Plus(s) technology and formulation as a:
Furthermore, with expanded qualitative and quantitative data from laboratory testing, herd performance, and casual observation, IFUS will initiate modifications, as required, to its formulation and application technology consistent with the requirements of specific geographic locations to ensure viable application of Supreme Gold Plus™.
The next level of validation requires the engagement of leading university beef and dairy scientists and nutritionists to assist in this highly-integrated testing and validation initiative. This is a phased and targeted approach with adjustments made to testing strategy and protocols based on statistically viable data that is both empirically accurate and precise as well as applied within given context.
'Testing will follow strict protocols outlined by established, scientific methods and best practices. The Company, has commenced testing at the ranch of one of our oldest customers located in North East Texas and another new customer in Louisiana.' stated Marc Walther CEO. 'Our decision to conduct testing with these ranchers is due in large part to their commitment in applying SGP+ not just as a mere supplement/food, but more so as a technological change in what and how cattle are to be fed in the future to secure maximum results.'
Customers who wish to participate in IFUS' breakthrough technology can apply by contacting the Company at [email protected].
About Impact Fusion International Inc.
Impact Fusion International, Inc. is in the business of marketing products in the 'Health and Wellness' sector of all international markets. It is the company's mission to invent, develop and market these proprietary products worldwide for the health and well-being of humans and animals.
The information contained in this release includes some statement that are not purely historical and that are 'forward-looking statements.' Such forward-looking statements include, but are not limited to, statements regarding our and their management's expectations, hopes, beliefs, intentions or strategies regarding the future, including our financial condition, results of operations. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words 'anticipates,' 'believes,' 'continue,' 'could,' 'estimates,' 'expects,' 'intends,' 'may,' 'might,' 'plans,' 'possible,' 'potential,' 'predicts,' 'projects,' 'seeks,' 'should,' 'would' and similar expressions, or the negatives of such terms, may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this release are based on current expectations and beliefs concerning future developments and the potential effects on the parties and the corporate and administrative transactions. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements and represent our management's beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements, even if new information becomes available in the future.
Updates can be found at the official Impact Fusion Twitter account @impactfusionl and $IFUS.
Contact:
Impact Fusion International Inc.
204 Highway 1011
Napoleonville LA 70390
1-800-775-4130
Email: [email protected]
https://www.impactfusionbrands.com/brands
https://www.impactfusionint.com
SOURCE: Impact Fusion International Inc.
Get a daily dose of Cleveland Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Cleveland Star.
More InformationNEW YORK, New York - U.S. stocks diverged on Wednesday for the second day in a row. The Standard and Poor's 500 hit a new all-time...
NEW YORK CITY, New York: The U.S. dollar continues to lose ground, weighed down by growing concerns over Washington's fiscal outlook...
KABUL, Afghanistan: Afghanistan, long associated with war and instability, is quietly trying to rebrand itself as a destination for...
SANTA CLARA, California: Executives at Nvidia have quietly been cashing in on the AI frenzy. According to a report by the Financial...
NEW YORK, New York - Global stock indices closed with divergent performances on Tuesday, as investors weighed corporate earnings, central...
TORONTO, Canada: Canadian Prime Minister Mark Carney announced late on June 29 that trade negotiations with the U.S. have recommenced...
ABU DHABI, 19th June, 2025 (WAM) -- Cleveland Clinic Abu Dhabi has become the first and only research hospital in the UAE to receive...
ABU DHABI, 17th June, 2025 (WAM) -- Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully introduced continuous infusion...
ABU DHABI, 9th June, 2025 (WAM) -- Cleveland Clinic Abu Dhabi has successfully performed the UAE's first robotic cytoreductive surgery...
ABU DHABI,16th May, 2025 (WAM) - Oracle Health, Cleveland Clinic, and G42 today announced a strategic partnership to develop a groundbreaking...
ABU DHABI, 6th May, 2025 (WAM) -- PureHealth and its subsidiary SEHA have partnered with the number one US children's hospital, Cincinnati...
Argentinian composer Lalo Schifrin, the genre-blending film and television composer behind the Mission: Impossible, Bullitt, and Cool...